Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

11 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-07-31

Study Completion Date

2013-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines the long term Safety Follow-up of first patients vaccinated with AD02.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who have received AD02 during AFF002 and AFF004A will be observed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer´s Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Vaccination follow-up

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* participation in AFF002 and AFF004A

Exclusion Criteria

* no vaccination with AD02

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Achim Schneeberger, MD

Role: STUDY_DIRECTOR

Sponsor GmbH

Siegfried Kasper, MD

Role: PRINCIPAL_INVESTIGATOR

Medical University Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Studienzentrum der PROSENEX Ambulatoriumsbetriebs GmbH

Vienna, Vienna, Austria

Site Status

Univ. Klinik für Psychiatire und Psychotherapie

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AFF004E

Identifier Type: -

Identifier Source: org_study_id